Oruka Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Oruka Therapeutics stock have an average target of 39.67, with a low estimate of 20 and a high estimate of 49. The average target predicts an increase of 331.20% from the current stock price of 9.20.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$39.67	$44	$49
Change	+117.39%	+331.20%	+378.26%	+432.61%

* Price targets were last updated on Feb 7, 2025.

Analyst Ratings

The average analyst rating for Oruka Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25
Strong Buy	4	4	4	4	4	4
Buy	2	2	2	3	3	3
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+389.13%	Feb 7, 2025
Andy Chen Wolfe Research	Wolfe Research	Buy Initiates $20	Buy	Initiates	$20	+117.39%	Feb 4, 2025
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+389.13%	Dec 20, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+389.13%	Nov 25, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+389.13%	Oct 31, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-2.51

from -4.23

EPS Next Year

-2.64

from -2.51

Fiscal Year	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-
Revenue Growth	-	-	-	-
EPS	-4.23	-2.51	-2.64	-2.32
EPS Growth	-	-	-	-
Forward PE	-	-	-	-
No. Analysts	-	9	7	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	n/a	n/a
Avg	n/a	n/a	n/a
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.19	-1.42	-1.26
Avg	-2.51	-2.64	-2.32
Low	-3.66	-4.06	-3.09

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.